Short leukocyte telomere length has been shown to predict survival across numerous ILD cohorts and subtypes (161–163) and patients with rare mutations in telomerase encoding genes, including TERT, TERC, PARN, and RTEL1 were shown to display survival similar to IPF irrespective of the clinical ILD diagnosis (164). This evidence concerns the gene TERC and interstitial lung disease.